Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Science. 2012 Aug 24;337(6097):975-80. doi: 10.1126/science.1222278.

    Phosphofructokinase 1 glycosylation regulates cell growth and metabolism.

    Source

    Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125, USA.

    Abstract

    Cancer cells must satisfy the metabolic demands of rapid cell growth within a continually changing microenvironment. We demonstrated that the dynamic posttranslational modification of proteins by O-linked β-N-acetylglucosamine (O-GlcNAcylation) is a key metabolic regulator of glucose metabolism. O-GlcNAcylation was induced at serine 529 of phosphofructokinase 1 (PFK1) in response to hypoxia. Glycosylation inhibited PFK1 activity and redirected glucose flux through the pentose phosphate pathway, thereby conferring a selective growth advantage on cancer cells. Blocking glycosylation of PFK1 at serine 529 reduced cancer cell proliferation in vitro and impaired tumor formation in vivo. These studies reveal a previously uncharacterized mechanism for the regulation of metabolic pathways in cancer and a possible target for therapeutic intervention.

    Comment in

    PMID:
    22923583
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3534962
    Free PMC Article

    Images from this publication.See all images (4)Free text

    Fig. 2
    Fig. 4
    Fig. 1
    Fig. 3

      Supplemental Content

      Icon for HighWire Icon for PubMed Central

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk